SBU HEAD – CRITICAL CARE

At Fresenius Medical Care, we are the global leader in kidney care, committed to improving the lives of patients with chronic kidney disease. Our mission is to deliver high-quality, innovative products, services, and care across the entire healthcare journey. Guided by our vision—“Creating a future worth living. For patients. Worldwide. Every day.”—we work with purpose and compassion, supported by a global team of over 125,000 employees.

Within our Care Enablement segment, we develop and provide life-sustaining medical products, digital health solutions, and therapies that empower clinical teams and improve patient outcomes. Our FME Reignite strategy drives transformation through innovation, efficiency, and sustainable growth.

Our values guide how we work:

• We Care for our patients, each other, and our communities

• We Connect across teams and borders to deliver excellence together

• We Commit to doing things the right way— growing with purpose and leading kidney care with integrity and innovation

Your Responsibilities:

• →
  • →
    • →

      Our Offer for you:

      There is a lot you can discover at Fresenius Medical Care, regardless in which field you are an expert and how much experience you have - all dedicated to your professional journey.

      • →

        Individual opportunities for self-determined career planning and professional development

      • →

        A corporate culture in which there is enough room for innovative thinking - to find the best solution together, not the quickest one

      • →

        A large number of committed people with a wide range of skills, talents and experience

      • →

        The benefits of a successful global corporation with the collegial culture of a medium-sized company

      • →

        Critical Care is one of FME India's highest-priority growth platforms. The therapy opportunity is large, underserved, and increasingly well-understood by the clinical community. What is needed now is not just a sales leader — but someone who can build an institution within an institution. The SBU Head will have the mandate, the resources, and the leadership support to do exactly that.

Develop and own the multi-year strategy for the Critical Care SBU — covering therapy portfolio positioning, market development roadmap, competitive differentiation, and revenue growth architecture. Translate the global FME Critical Care vision into an India-specific strategy that accounts for the unique market dynamics of public, private, and emerging healthcare segments.

Full accountability for the Critical Care SBU's revenue, margin, and cost structure. Drive sustainable, profitable growth through disciplined resource allocation, pricing strategy, and investment prioritisation. Own the annual operating plan and present business performance to the MD and regional leadership with clarity and conviction.

Work closely with global product management and the regional marketing team to shape the India portfolio roadmap. Identify therapy gaps, unmet clinical needs, and market entry opportunities — and translate them into concrete product and therapy development priorities. Champion CRRT, HVHDF, and adjacent critical care therapies with both clinical and commercial rigour.

Define and execute a market development strategy that expands the addressable critical care universe in India — across corporate chains, standalone tertiary hospitals, government medical institutions, and emerging ICU setups in Tier 2 and Tier 3 cities. Build a scalable model that regional teams can execute with consistency.

Ultimately accountable for the SBU's top-line performance. Drive a results-oriented culture within the team while ensuring the commercial approach is grounded in clinical value — not just transaction. Balance short-term target delivery with long-term account and therapy development.

Own relationships with the most strategically significant accounts in the country — large hospital chains, apex government institutions, and key academic medical centres. These require seniority, clinical credibility, and long-term continuity, and the SBU Head must invest in them personally.

Develop a structured approach to government and institutional tenders — understanding procurement cycles, decision hierarchies, and compliance requirements across states. Identify and pursue large-scale public health opportunities where FME's Critical Care portfolio can create systemic impact.

Define and govern the regional pricing framework for the Critical Care portfolio in alignment with global and regional guidelines. Ensure commercial policy is consistently applied while retaining the flexibility to respond to competitive and market-specific dynamics.

Lead, inspire, and develop the Critical Care commercial organisation — Regional Managers, Product Specialists, and cross-functional partners. Create a high-performance culture equally driven by clinical purpose and commercial ambition. The SBU Head sets the standard for what good looks like — in the field, in the boardroom, and in every customer interaction.

Actively build the next generation of Critical Care leaders within FME India. Identify high-potential individuals early, create stretch opportunities, and work with HR to build structured development plans. The measure of this role's success includes the quality of talent it produces.

Own workforce planning for the SBU — assessing where the team needs to grow, what capabilities are missing, and how to structure the organisation for the next phase. Partner with HR on recruitment, onboarding, and capability frameworks.

Build and lead a national KOL engagement programme across critical care and nephrology. Develop relationships with thought leaders at a level where FME India becomes a genuine scientific and clinical partner — not just a device vendor. Support, co-create, and participate in clinical education initiatives, symposia, and publications.

Champion the clinical evidence base for FME's Critical Care therapies. Work with the global medical affairs team to generate India-relevant clinical data, real-world evidence, and therapy outcome metrics that strengthen FME's position with both clinicians and institutional payers.

Represent FME at national and regional critical care and nephrology forums — ISCCM, ISN, and equivalent bodies. Build FME's institutional credibility through active participation, not passive presence.

• Critical Care SBU revenue and margin — annual and quarterly
• Market share growth across CRRT and HVHDF therapy segments
• New account acquisition and therapy initiation metrics
• Team performance — productivity per specialist, regional coverage depth
• KOL network quality — breadth, activation level, and advocacy output
• Talent pipeline — promotable individuals identified and in active development
• Annual operating plan submitted on time and executed with discipline
• Strategic account relationships — personally owned and actively managed

Bring an owner's lens to every decision — balancing growth investment with return, short-term pressure with long-term positioning, and team needs with organisational priorities. This role is measured on the health of the business, not just the current quarter's numbers.

The best candidate will have earned genuine clinical respect — able to walk into an ICU and hold a credible conversation with a senior intensivist — while being razor-sharp on commercial execution. One without the other is insufficient for this role.

Work constructively across Sales, Marketing, Technical Services, Clinical, Finance, and HR to drive integrated outcomes. But maintain a clear point of view — this role requires strong convictions, clearly communicated and well-defended.

Represent FME India at the highest levels — with customers, at conferences, and with regulatory and government bodies where relevant. The SBU Head is not a back-office leader; they are the visible, credible, and trusted face of FME's Critical Care commitment in India.

Your Profile: